Title : Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.

Pub. Date : 2015 May 30

PMID : 25743173






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to investigate the safety and efficacy of anacetrapib, a cholesteryl ester transfer protein inhibitor, in patients with heterozygous familial hypercholesterolaemia. anacetrapib cholesteryl ester transfer protein Homo sapiens